Phreesia (PHR)
(Delayed Data from NYSE)
$20.61 USD
+0.15 (0.73%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $20.58 -0.03 (-0.15%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth C Momentum B VGM
Income Statements
Fiscal Year end for Phreesia, Inc falls in the month of January .
All items in Millions except EPS data.
1/31/24 | 1/31/23 | 1/31/22 | 1/31/21 | 1/31/20 | |
---|---|---|---|---|---|
Sales | 356 | 281 | 213 | 149 | 125 |
Cost Of Goods | 124 | 109 | 81 | 52 | 45 |
Gross Profit | 232 | 172 | 132 | 96 | 80 |
Selling & Adminstrative & Depr. & Amort Expenses | 369 | 348 | 249 | 122 | 95 |
Income After Depreciation & Amortization | -136 | -177 | -117 | -26 | -15 |
Non-Operating Income | 1 | 1 | -1 | -2 | -7 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -135 | -176 | -118 | -27 | -22 |
Income Taxes | 2 | 0 | 0 | 0 | -2 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -137 | -176 | -118 | -27 | -20 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -137 | -176 | -118 | -27 | -20 |
Depreciation Footnote | 1/31/24 | 1/31/23 | 1/31/22 | 1/31/21 | 1/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -106 | -149 | -93 | -7 | 1 |
Depreciation & Amortization (Cash Flow) | 31 | 27 | 24 | 18 | 16 |
Income After Depreciation & Amortization | -136 | -177 | -117 | -26 | -15 |
Earnings Per Share Data | 1/31/24 | 1/31/23 | 1/31/22 | 1/31/21 | 1/31/20 |
---|---|---|---|---|---|
Average Shares | 54.56 | 52.44 | 49.89 | 39.52 | 20.30 |
Diluted EPS Before Non-Recurring Items | -2.51 | -3.36 | -2.37 | -0.69 | -4.50 |
Diluted Net EPS (GAAP) | -2.51 | -3.36 | -2.37 | -0.69 | -4.50 |
Fiscal Year end for Phreesia, Inc falls in the month of January .
All items in Millions except EPS data.
1/31/24 | 10/31/23 | 7/31/23 | 4/30/23 | 1/31/23 | |
---|---|---|---|---|---|
Sales | 95.00 | 91.62 | 85.83 | 83.85 | 76.59 |
Cost Of Goods | 31.77 | 30.94 | 30.30 | 31.00 | 27.96 |
Gross Profit | 63.23 | 60.68 | 55.53 | 52.85 | 48.62 |
SG&A, R&D, and Dept/Amort Expenses | 92.80 | 92.72 | 92.48 | 90.75 | 88.44 |
Income After SG&A, R&D, and Dept/Amort Expenses | -29.57 | -32.04 | -36.95 | -37.90 | -39.82 |
Non-Operating Income | -0.85 | 0.48 | 0.84 | 0.68 | 1.62 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -30.43 | -31.57 | -36.12 | -37.23 | -38.19 |
Income Taxes | 0.22 | 0.37 | 0.65 | 0.31 | -0.17 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -30.65 | -31.94 | -36.77 | -37.53 | -38.02 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -30.65 | -31.94 | -36.77 | -37.53 | -38.02 |
Earnings Per Share Data | 1/31/24 | 10/31/23 | 7/31/23 | 4/30/23 | 1/31/23 |
---|---|---|---|---|---|
Average Shares | 54.56 | 55.25 | 53.79 | 53.35 | 52.87 |
Diluted EPS Before Non-Recurring Items | -0.56 | -0.58 | -0.68 | -0.70 | -0.72 |
Diluted Net EPS (GAAP) | -0.55 | -0.58 | -0.68 | -0.70 | -0.72 |